Article Details
Retrieved on: 2022-06-28 15:16:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... in patients with unresectable, NF2-deficient malignant pleural mesothelioma, according to Ikena Oncology, the developer of the novel therapy.
Article found on: www.curetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here